This was also consistent with the abovementioned study by Wen et al. [15], which found that compared to HCs, the absolute number of CD8+ T cells, NK cells, and CD4+ T cells decreased in COVID-19 patients, especially in the recovery stage; however, they observed no significant changes in CD19+ B cell counts, unlike in our study. The gene discussed is CD4; the disease is COVID-19.